Abstract
Pancreatic ß cells within the islets of Langerhans are the body’s main source for insulin. ß cells maintain glucose homeostasis through the tight control of insulin secretion and cessation in response to changes in blood glucose levels. The loss of ß cells or ß-cell dysfunction leads to the development of diabetes. Diabetes is a prevalent metabolic disease that affects populations worldwide. Considerable efforts are underway to develop therapies and treatments to combat diabetes. Transplantation of stem cell-derived ß cells (SC-ß cells) is a promising cell replacement therapy for curing diabetes. Significant advancements have been made toward generating functional SC-ß cells in laboratories. Here, we describe the essential properties of human ß cells that need to be reproduced in stem cell-derived insulin-producing cells to ensure functionality and safety.
Original language | English |
---|---|
Title of host publication | Pluripotent Stem Cell Therapy for Diabetes, First Edition |
Publisher | Springer International Publishing |
Pages | 529-545 |
Number of pages | 17 |
ISBN (Electronic) | 9783031419430 |
ISBN (Print) | 9783031419423 |
DOIs | |
State | Published - 1 Jan 2024 |
Keywords
- Ca signaling
- Clinical trial
- Diabetes
- First-phase and second-phase insulin secretion
- Insulin secretion
- Islets of Langerhans
- Metabolism
- SC-ß cells
- ß cells
- ß-cell maturation